Results 171 to 180 of about 100,703 (254)
Biomarkers of pulmonary fibrosis in bronchoalveolar lavage fluid and saliva. Study methods and pathophysiological significance. [PDF]
Ángel-Reimúndez C +6 more
europepmc +1 more source
ABSTRACT Bioassays offer functional readouts of immune responses through specific biomarkers, providing mechanistic insight beyond conventional serology. By capturing cellular activation, tissue‐level changes, and molecular signaling, they hold promise for refining allergy diagnosis, risk stratification, and treatment monitoring, contributing to ...
Cagatay Karaaslan +13 more
wiley +1 more source
Expression of Concern: Detection of Plant DNA in the Bronchoalveolar Lavage of Patients with Ventilator-Associated Pneumonia. [PDF]
PLOS One Editors.
europepmc +1 more source
Abstract Background Primary pulmonary salivary gland‐type tumors (PSGTs) are rare but clinically significant tumors that originate from the submucosal glands of the tracheobronchial tree. Cytologic samples taken during bronchoscopy are a key component of preoperative evaluation. However, cytologic diagnosis remains challenging because of the submucosal
Henri Lagerstam +2 more
wiley +1 more source
Diagnostic Performance of Bronchoalveolar Lavage Fluid Metagenomic Next‑generation Sequencing versus Conventional Microbiological Tests in Immunocompromised and Immunocompetent Patients with Pulmonary Infection. [PDF]
Song Y, Xu C, Zu F, Dong R, Yang H.
europepmc +1 more source
In this study, we found that sinensetin can effectively inhibit the inflammatory response and damage of lung cells caused by LPS in vivo and in vitro. This might be caused by the action of sinensetin in regulating the HIF‐1α‐MAPK signaling cascade.
Zuomin Hu +9 more
wiley +1 more source
Use of the Proportion of Neutrophils in Bronchoalveolar Lavage Fluid for Rapid Diagnosis of Bacterial Pneumonia in Children. [PDF]
Ke C, Zhai X, Ao D, Liu X, Mo X, Han H.
europepmc +1 more source
Parasite‐Derived IL‐33 Inhibitors Prevent Bleomycin‐Induced Lung Fibrosis
Infection with the intestinal helminth Heligmosomoides polygyrus bakeri, or administration of the parasite products (HES), or administration of recombinant HpARI2+HpBARI_Hom2 can all suppress the development of lung fibrosis in the mouse bleomycin model, via suppression of the IL‐33 pathway. Graphic abstract created in BioRender. McSorley, HJ.
Samuele Di Carmine +11 more
wiley +1 more source

